Risk Factors Associated With Child Food Allergy Identified
via HealthDayTUESDAY, Feb. 17, 2026 -- A combination of major and minor risk factors encompasses the most credible factors associated with development of childhood food allergy, according to a study published online Feb. 9 in JAMA Pediatrics.
Nazmul Islam, M.B.B.S., M.P.H., from McMaster University in Hamilton, Ontario, Canada, and colleagues estimated the incidence of and quantified risk factors for food allergy development in a systematic review of the literature. The analyses included 190 studies involving 2.8 million participants across 40 countries.
The researchers found that the overall food allergy incidence was likely 4.7 percent (moderate certainty) among studies using food challenge. Of the 176 studies that identified 342 risk factors with varying certainty, the strongest and most certain factors were prior allergic conditions within the first year of life, allergic rhinitis, and wheeze (odds ratios [ORs], 3.88, 3.39, and 2.11, respectively). Additional factors included severity of atopic dermatitis (OR, 1.22), increased skin transepidermal water loss (OR, 3.36), filaggrin gene sequence variations (OR, 1.93), delayed solid food introduction (e.g., peanut after 12 months [OR, 2.55]), infant antibiotic use (ORs, 4.11 and 1.39 for first month and first year, respectively), and family history of food allergy (ORs, 1.98, 1.69, and 2.07 for father, mother, and both parents, respectively). No significant risk differences were seen for low birth weight, postterm birth, maternal diet, or stress during pregnancy.
"Our study highlights that genetics alone cannot fully explain food allergy trends, pointing to interactions -- or a 'perfect storm' -- between genes, skin health, the microbiome, and environmental exposures," senior author Derek K. Chu, M.D., Ph.D., also from McMaster University, said in a statement.
Several authors disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-18 13:38
Read more
- U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
- Recommendations Developed for Primary Care Asthma Management in Veterans, Military Members
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- FDA Approves Label Update for Kite’s Yescarta for Relapsed/Refractory Primary Central Nervous System Lymphoma
- NIH Halts Arm of Clinical Trial Evaluating a Potential Stroke Treatment
- PTC Therapeutics Provides Regulatory Update on Translarna
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions